Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

SIFY vs HCTI

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SIFY
Sify Technologies Limited

Telecommunications Services

Communication ServicesNASDAQ • IN
Market Cap$1.06B
5Y Perf.-28.5%
HCTI
Healthcare Triangle, Inc.

Medical - Healthcare Information Services

HealthcareNASDAQ • US
Market Cap$49K
5Y Perf.-100.0%

SIFY vs HCTI — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SIFY logoSIFY
HCTI logoHCTI
IndustryTelecommunications ServicesMedical - Healthcare Information Services
Market Cap$1.06B$49K
Revenue (TTM)$41.45B$13M
Net Income (TTM)$-1.50B$-6M
Gross Margin34.2%13.1%
Operating Margin5.2%-45.2%
Total Debt$39.51B$3M
Cash & Equiv.$5.00B$20K

SIFY vs HCTILong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SIFY
HCTI
StockOct 21May 26Return
Sify Technologies L… (SIFY)10071.5-28.5%
Healthcare Triangle… (HCTI)1000.0-100.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: SIFY vs HCTI

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: SIFY leads in 6 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
SIFY
Sify Technologies Limited
The Income Pick

SIFY carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 0 yrs, beta 1.33, yield 0.0%
  • Rev growth 11.9%, EPS growth -8.8%, 3Y rev CAGR 13.9%
  • 120.6% 10Y total return vs HCTI's -100.0%
Best for: income & stability and growth exposure
HCTI
Healthcare Triangle, Inc.
The Specific-Use Pick

In this particular matchup, HCTI is outpaced on most metrics by others in the set.

Best for: healthcare exposure
See the full category breakdown
CategoryWinnerWhy
GrowthSIFY logoSIFY11.9% revenue growth vs HCTI's -64.8%
Quality / MarginsSIFY logoSIFY-3.6% margin vs HCTI's -48.9%
Stability / SafetySIFY logoSIFYBeta 1.33 vs HCTI's 3.07
DividendsSIFY logoSIFY0.0% yield; the other pay no meaningful dividend
Momentum (1Y)SIFY logoSIFY+222.5% vs HCTI's -99.9%
Efficiency (ROA)SIFY logoSIFY-1.8% ROA vs HCTI's -60.0%, ROIC 3.3% vs -6.3%

SIFY vs HCTI — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SIFYSify Technologies Limited

Segment breakdown not available.

HCTIHealthcare Triangle, Inc.
FY 2022
Software Services
54.4%$24M
Managed Services And Support
34.6%$15M
Platform Services
11.0%$5M

SIFY vs HCTI — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLSIFYLAGGINGHCTI

Income & Cash Flow (Last 12 Months)

SIFY leads this category, winning 4 of 6 comparable metrics.

SIFY is the larger business by revenue, generating $41.4B annually — 3202.7x HCTI's $13M. SIFY is the more profitable business, keeping -3.6% of every revenue dollar as net income compared to HCTI's -48.9%. On growth, HCTI holds the edge at +44.6% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSIFY logoSIFYSify Technologies…HCTI logoHCTIHealthcare Triang…
RevenueTrailing 12 months$41.4B$13M
EBITDAEarnings before interest/tax$8.1B-$6M
Net IncomeAfter-tax profit-$1.5B-$6M
Free Cash FlowCash after capex$0-$12M
Gross MarginGross profit ÷ Revenue+34.2%+13.1%
Operating MarginEBIT ÷ Revenue+5.2%-45.2%
Net MarginNet income ÷ Revenue-3.6%-48.9%
FCF MarginFCF ÷ Revenue-9.2%-94.7%
Rev. Growth (YoY)Latest quarter vs prior year+2.5%+44.6%
EPS Growth (YoY)Latest quarter vs prior year-3.7%-63.8%
SIFY leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

Evenly matched — SIFY and HCTI each lead in 1 of 2 comparable metrics.
MetricSIFY logoSIFYSify Technologies…HCTI logoHCTIHealthcare Triang…
Market CapShares × price$1.1B$48,541
Enterprise ValueMkt cap + debt − cash$1.4B$3M
Trailing P/EPrice ÷ TTM EPS-110.80x-0.01x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple17.18x
Price / SalesMarket cap ÷ Revenue2.53x0.00x
Price / BookPrice ÷ Book value/share4.31x
Price / FCFMarket cap ÷ FCF
Evenly matched — SIFY and HCTI each lead in 1 of 2 comparable metrics.

Profitability & Efficiency

SIFY leads this category, winning 4 of 6 comparable metrics.

SIFY delivers a -7.7% return on equity — every $100 of shareholder capital generates $-8 in annual profit, vs $-113 for HCTI.

MetricSIFY logoSIFYSify Technologies…HCTI logoHCTIHealthcare Triang…
ROE (TTM)Return on equity-7.7%-112.9%
ROA (TTM)Return on assets-1.8%-60.0%
ROICReturn on invested capital+3.3%-6.3%
ROCEReturn on capital employed+4.4%
Piotroski ScoreFundamental quality 0–933
Debt / EquityFinancial leverage1.96x
Net DebtTotal debt minus cash$34.5B$3M
Cash & Equiv.Liquid assets$5.0B$20,000
Total DebtShort + long-term debt$39.5B$3M
Interest CoverageEBIT ÷ Interest expense0.82x-3.79x
SIFY leads this category, winning 4 of 6 comparable metrics.

Total Returns (Dividends Reinvested)

SIFY leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in SIFY five years ago would be worth $8,652 today (with dividends reinvested), compared to $0 for HCTI. Over the past 12 months, SIFY leads with a +222.5% total return vs HCTI's -99.9%. The 3-year compound annual growth rate (CAGR) favors SIFY at 24.2% vs HCTI's -96.0% — a key indicator of consistent wealth creation.

MetricSIFY logoSIFYSify Technologies…HCTI logoHCTIHealthcare Triang…
YTD ReturnYear-to-date+19.1%-93.7%
1-Year ReturnPast 12 months+222.5%-99.9%
3-Year ReturnCumulative with dividends+91.4%-100.0%
5-Year ReturnCumulative with dividends-13.5%-100.0%
10-Year ReturnCumulative with dividends+120.6%-100.0%
CAGR (3Y)Annualised 3-year return+24.2%-96.0%
SIFY leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

SIFY leads this category, winning 2 of 2 comparable metrics.

SIFY is the less volatile stock with a 1.33 beta — it tends to amplify market swings less than HCTI's 3.07 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SIFY currently trades 82.0% from its 52-week high vs HCTI's 0.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSIFY logoSIFYSify Technologies…HCTI logoHCTIHealthcare Triang…
Beta (5Y)Sensitivity to S&P 5001.33x3.07x
52-Week HighHighest price in past year$17.85$7410.00
52-Week LowLowest price in past year$3.95$0.29
% of 52W HighCurrent price vs 52-week peak+82.0%+0.0%
RSI (14)Momentum oscillator 0–10051.430.1
Avg Volume (50D)Average daily shares traded60K675K
SIFY leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.
MetricSIFY logoSIFYSify Technologies…HCTI logoHCTIHealthcare Triang…
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target
# AnalystsCovering analysts1
Dividend YieldAnnual dividend ÷ price+0.0%
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS$0.36
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

SIFY leads in 4 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 1 category is tied.

Best OverallSify Technologies Limited (SIFY)Leads 4 of 6 categories
Loading custom metrics...

SIFY vs HCTI: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is SIFY or HCTI a better buy right now?

For growth investors, Sify Technologies Limited (SIFY) is the stronger pick with 11.

9% revenue growth year-over-year, versus -64. 8% for Healthcare Triangle, Inc. (HCTI). Analysts rate Sify Technologies Limited (SIFY) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — SIFY or HCTI?

Over the past 5 years, Sify Technologies Limited (SIFY) delivered a total return of -13.

5%, compared to -100. 0% for Healthcare Triangle, Inc. (HCTI). Over 10 years, the gap is even starker: SIFY returned +129. 9% versus HCTI's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — SIFY or HCTI?

By beta (market sensitivity over 5 years), Sify Technologies Limited (SIFY) is the lower-risk stock at 1.

33β versus Healthcare Triangle, Inc. 's 3. 07β — meaning HCTI is approximately 132% more volatile than SIFY relative to the S&P 500.

04

Which is growing faster — SIFY or HCTI?

By revenue growth (latest reported year), Sify Technologies Limited (SIFY) is pulling ahead at 11.

9% versus -64. 8% for Healthcare Triangle, Inc. (HCTI). On earnings-per-share growth, the picture is similar: Healthcare Triangle, Inc. grew EPS 45. 6% year-over-year, compared to -877. 8% for Sify Technologies Limited. Over a 3-year CAGR, SIFY leads at 13. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — SIFY or HCTI?

Sify Technologies Limited (SIFY) is the more profitable company, earning -2.

0% net margin versus -51. 0% for Healthcare Triangle, Inc. — meaning it keeps -2. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SIFY leads at 5. 7% versus -40. 6% for HCTI. At the gross margin level — before operating expenses — SIFY leads at 37. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — SIFY or HCTI?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is SIFY or HCTI better for a retirement portfolio?

For long-horizon retirement investors, Sify Technologies Limited (SIFY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+129.

9% 10Y return). Healthcare Triangle, Inc. (HCTI) carries a higher beta of 3. 07 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SIFY: +129. 9%, HCTI: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between SIFY and HCTI?

These companies operate in different sectors (SIFY (Communication Services) and HCTI (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

SIFY

Quality Business

  • Sector: Communication Services
  • Market Cap > $100B
  • Gross Margin > 20%
Run This Screen
Stocks Like

HCTI

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $2B
  • Revenue Growth > 22%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform SIFY and HCTI on the metrics below

Revenue Growth>
%
(SIFY: 2.5% · HCTI: 44.6%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.